Neoplasms

Respiratory Tract (Lung and Bronchial) Diseases

All Conditions

Nervous System Diseases

Behaviors and Mental Disorders

Symptoms and General Pathology

Lung Neoplasms

Sleep Initiation and Maintenance Disorders

Respiratory Tract Neoplasms

Thoracic Neoplasms

Lung Diseases

Respiratory Tract Diseases

Parasomnias

Sleep Disorders, Intrinsic

Dyssomnias

Sleep Wake Disorders

Mental Disorders

Psychotic Disorders

This group will be receiving an assisted relaxation therapy intervention

This group will be receiving a modified version of an assisted relaxation therapy intervention

This intervention includes using a smartphone application that helps with breathing techniques and sleep.

Assisted Relaxation Therapy

This intervention includes using a smartphone application that is modified to help with breathing techniques and additional sleep instructions.

Modified Assisted Relaxation Therapy

Nalaka S Gooneratne, MD

This is a randomized, 30-day research study that is exploring the effects of two simplified mindfulness interventions in lung cancer patients aimed to improve their sleep quality and anxiety regarding sleep. The investigators will be enrolling a total of 20 patients who have insomnia symptoms. Patients will use a behavioral intervention to help with their sleep.

The objective is to implement and examine the outcomes of a simplified relaxation intervention, Assisted Relaxation Therapy (ART), for lung cancer patients who experience insomnia symptoms and other sleep difficulties. This intervention includes using a smartphone application. A variety of surveys will be used to track the interventions' efficacy throughout the study. To test these interventions, the investigators will recruit participants (n=20) from a weekly oncology patient list located within the University of Pennsylvania. Participants with a history of lung cancer who are recruited into the study must have a smartphone. Participants will use the ART intervention over the course of 2 weeks and will receive surveys at enrollment (D0), end of intervention (D14) and 2 weeks post-intervention (D30). Missing data will be handled using imputation methods. The investigators will analyze the data using statistical programs to determine progress throughout the study.

This will be conducted as a parallel group, single-blinded pilot study for reducing insomnia among lung cancer patients. All subjects will participate in some form of insomnia treatment over a fourteen-day period. Participants eligible and enrolled in the study will be randomized into one of the two arms, which consist of the two different ART. Randomization and survey baseline measurements from eligible participants will occur on day -1 and the intervention period will last until day fourteen. On day thirty, two weeks post intervention(s), surveys will be emailed to participants to track any change in sleep quality, respiratory quality, and perception of sleep.

Behavioral Relaxation Approaches for Insomnia in Lung Cancer Patients

Changes in sleep onset latency will be measured by sleep diary.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Behavioral Relaxation Approaches for Insomnia in Lung Cancer Patients	NCT04318249	Insomnia	Assisted Relaxa... Modified Assist...	18 Years - 85 Years	Abramson Cancer Center at Penn Medicine
Behavioral Relaxation Approaches for Insomnia in Lung Cancer Patients	NCT04318249	Insomnia	Assisted Relaxa... Modified Assist...	18 Years - 85 Years	Abramson Cancer Center at Penn Medicine

Spots Global Cancer Trial Database for assisted relaxation therapy